Panacea Biotec Ltd — Vaccine Exporter Profile
Indian Pharmaceutical Exporter · #15 for Vaccine · $600.0K export value · DGFT Verified
Panacea Biotec Ltd is the #15 Indian exporter of Vaccine with $600.0K in export value and 12 verified shipments. Panacea Biotec Ltd holds a 0.1% market share in Vaccine exports across 9 countries.
Panacea Biotec Ltd — Vaccine Export Profile: Buyers & Destinations
Where Does Panacea Biotec Ltd Export Vaccine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BANGLADESH | $1.7M | 36 | 16.9% |
| BRAZIL | $1.4M | 28 | 13.5% |
| SUDAN | $1.1M | 21 | 10.2% |
| PAKISTAN | $950.0K | 21 | 9.2% |
| MOZAMBIQUE | $550.0K | 11 | 5.3% |
| INDONESIA | $450.0K | 9 | 4.4% |
| BOLIVIA | $300.0K | 6 | 2.9% |
| AFGHANISTAN | $300.0K | 6 | 2.9% |
| CUBA | $299.2K | 7 | 2.9% |
| JAMAICA | $202.4K | 6 | 2.0% |
Panacea Biotec Ltd exports Vaccine to 63 countries. The largest destination is BANGLADESH accounting for 16.9% of Panacea Biotec Ltd's Vaccine shipments, followed by BRAZIL (13.5%) and SUDAN (10.2%). These destinations reflect Panacea Biotec Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vaccine from Panacea Biotec Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MINISTERIO DA SAUDE/DEPARTAMENTO DE | BRAZIL | $1.1M | 23 |
| D.G. CENTRAL MEDICAL STORES DEPT. | BANGLADESH | $1.1M | 23 |
| GENERAL DIRECTORATE OF GLOBAL HEALT | SUDAN | $1.0M | 20 |
| PT BANK MANDIRI (PERSERO) TBK | INDONESIA | $450.0K | 9 |
| D G CENTRAL MEDICAL STORES DEPT | BANGLADESH | $400.0K | 8 |
| EPI MANAGER MINISTRY OF HEALTH P | MOZAMBIQUE | $350.0K | 7 |
| CENTRE FOR GENETIC ENGINEERING AND | CUBA | $299.0K | 6 |
| MINISTERIO DE SALUD Y DEPORTES | BOLIVIA | $250.0K | 5 |
| EXPANDED PROGRAMME ON IMMUNIZATION | PAKISTAN | $250.0K | 5 |
| MINISTRY OF HEALTH AND WELLNESS | JAMAICA | $202.4K | 6 |
Panacea Biotec Ltd supplies Vaccine to 94 buyers globally. The largest buyer is MINISTERIO DA SAUDE/DEPARTAMENTO DE (BRAZIL), followed by D.G. CENTRAL MEDICAL STORES DEPT. (BANGLADESH) and GENERAL DIRECTORATE OF GLOBAL HEALT (SUDAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vaccine Export Value and How Much Does Panacea Biotec Ltd Contribute?
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Panacea Biotec Ltd contributes $600.0K to this total, accounting for 0.1% of India's Vaccine exports. Panacea Biotec Ltd ships Vaccine to 63 countries through 94 buyers.
What Is the Average Shipment Value for Panacea Biotec Ltd's Vaccine Exports?
Panacea Biotec Ltd's average Vaccine shipment value is $50.0K per consignment, based on 12 shipments totaling $600.0K. The largest destination is BANGLADESH (16.9% of Panacea Biotec Ltd's Vaccine exports).
How Does Panacea Biotec Ltd Compare to Other Indian Vaccine Exporters?
Panacea Biotec Ltd ranks #15 among 325 Indian Vaccine exporters with a 0.1% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Panacea Biotec Ltd processed 12 shipments to 9 destination countries.
What Vaccine Formulations Does Panacea Biotec Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTA | $3.7M | 77 |
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTAVALENT VACCINE (EACH VIAL OF 0.5 ML CONTAINS 1 DOSE) WITH VACCINE VIAL MONITOR B | $700.0K | 14 |
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTAVALENT VACCINE EACH VIAL OF 0.5 ML CONTAINS 1 DOSE WITH VACCINE VIAL MONITOR B | $449.5K | 11 |
| BIVALENT TYPE 1 TYPE3 ORAL POLIOMYELITIS VACCINE bOPV 20 DOSE VIAL LIVEORAL SABIN STRAIN BIVALENT READY FOR U | $427.6K | 9 |
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTAVALENT VACCINE EACH VIAL OF 0.5 ML CONTAINS 1 DOSE EASY FIVE TT VACCINE WITH V | $354.2K | 8 |
| EASY FIVE TT VACCINE DTWP-HEP B-HIB PENTAVALENT VACCINE (EACH VIAL OF 5.0 ML CONTAINS 10 DOSES) WITH VACCINE VIAL MONITO | $350.0K | 7 |
| EASY FIVE TT VACCINE DTwP HepB HIB PENTAVALENT VACCINE EACH VIAL OF 0 5 ML CONTAINS 1 DOSE WITH VACCINE VIAL MONITOR B | $350.0K | 7 |
| EASY FIVE TT VACCINE DTWP-HEPB-HIB PENTAVALENT VACCINE (EACH VIAL OF 0.5 ML CONTAINS 1 DOSE) WITH VACCINE VIAL MONITOR B | $250.0K | 5 |
| BIVALENT TYPE 1 TYPE3 ORAL POLIOMYELITIS VACCINE bOPV 20 DOSE VIAL LIVE ORAL SABIN STRAIN BIVALENT READY FOR USE | $250.0K | 5 |
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTAVALENT VACCINE EACH VIAL OF 0.5 ML CONTAINS 1 DOSE B/N.E5V013096 M/D.06/2023 | $200.0K | 4 |
Panacea Biotec Ltd exports 70 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EASY FIVE TT VACCINE DTwP-HepB-HIB PENTA with 77 shipments worth $3.7M.
Regulatory Requirements: Exporting Vaccine to Key Markets
What Panacea Biotec Ltd must comply with to export Vaccine to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Panacea Biotec Ltd Compare to Nearest Vaccine Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | BIOLOGICAL E LTD | $2.3M | 46 | 25 | $50.0K |
| 11 | BHARAT BIOTECH INTERNATIONAL LTD | $1.2M | 24 | 14 | $50.0K |
| 15 | PANACEA BIOTEC LTD ★ | $600.0K | 12 | 9 | $50.0K |
Panacea Biotec Ltd ranks #15 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are BIOLOGICAL E LTD and BHARAT BIOTECH INTERNATIONAL LTD.
Which Indian Ports Ship Vaccine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Panacea Biotec Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 246 individual customs records matching Panacea Biotec Ltd exporting Vaccine, covering 70 formulations to 63 countries via 94 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Export Data from Panacea Biotec Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Panacea Biotec Ltd's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Panacea Biotec Ltd
Company Profile
0 products · $0 total trade · 0 categories
Vaccine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Panacea Biotec Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.